Comparability of plasma iohexol clearance across population-based cohorts

Rationale & Objective: Glomerular filtration rate (GFR) estimation based on creatinine or cystatin C level is currently the standard method for assessing GFR in epidemiologic research and clinical trials despite several important and well-known limitations. Plasma iohexol clearance has been prop...

Full description

Bibliographic Details
Published in:American Journal of Kidney Diseases
Main Authors: Eriksen, Bjørn Odvar, Schaeffner, Elke, Melsom, Toralf, Ebert, Natalie, van der Giet, Markus, Gudnason, Vilmundur, Indridasson, Olafur S., Karger, Amy B., Levey, Andrew S., Schuchardt, Mirjam, Sørensen, Liv Karin, Pálsson, Runólfur
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier 2019
Subjects:
Online Access:https://hdl.handle.net/10037/26856
https://doi.org/10.1053/j.ajkd.2019.10.008
id ftunivtroemsoe:oai:munin.uit.no:10037/26856
record_format openpolar
spelling ftunivtroemsoe:oai:munin.uit.no:10037/26856 2023-05-15T17:39:23+02:00 Comparability of plasma iohexol clearance across population-based cohorts Eriksen, Bjørn Odvar Schaeffner, Elke Melsom, Toralf Ebert, Natalie van der Giet, Markus Gudnason, Vilmundur Indridasson, Olafur S. Karger, Amy B. Levey, Andrew S. Schuchardt, Mirjam Sørensen, Liv Karin Pálsson, Runólfur 2019-12-23 https://hdl.handle.net/10037/26856 https://doi.org/10.1053/j.ajkd.2019.10.008 eng eng Elsevier American Journal of Kidney Diseases Eriksen BO, Schaeffner E, Melsom T, Ebert N, van der Giet M, Gudnason V, Indridasson, Karger, Levey AS, Schuchardt, Sørensen LK, Pálsson R. Comparability of plasma iohexol clearance across population-based cohorts. American Journal of Kidney Diseases. 2019, 76(1):54-62. FRIDAID 1779098 doi:10.1053/j.ajkd.2019.10.008 0272-6386 1523-6838 https://hdl.handle.net/10037/26856 openAccess Copyright 2019 The Author(s) Journal article Tidsskriftartikkel Peer reviewed publishedVersion 2019 ftunivtroemsoe https://doi.org/10.1053/j.ajkd.2019.10.008 2022-09-21T23:00:39Z Rationale & Objective: Glomerular filtration rate (GFR) estimation based on creatinine or cystatin C level is currently the standard method for assessing GFR in epidemiologic research and clinical trials despite several important and well-known limitations. Plasma iohexol clearance has been proposed as an inexpensive method for measuring GFR that could replace estimated GFR in many research projects. However, lack of standardization for iohexol assays and the use of different protocols such as single- and multiplesample methods could potentially hamper comparisons across studies. We compared iohexol assays and GFR measurement protocols in 3 population-based European cohorts. Study Design: Cross-sectional investigation. Setting & Participants: Participants in the Age, Gene/Environment Susceptibility-Kidney Study (AGES-Kidney; n = 805), the Berlin Initiative Study (BIS, n = 570), and the Renal Iohexol Clearance Survey Follow-up Study (RENIS-FU; n = 1,324). Tests Compared: High-performance liquid chromatography analyses of iohexol. Plasma iohexol clearance calculated using single- versus multiple-sample protocols. Outcomes: Measures of agreement between methods. Results: Frozen samples from the 3 studies were obtained and iohexol concentrations were remeasured in the laboratory at the University Hospital of North Norway. Lin’s concordance correlation coefficient ρ was >0.96 and Cb (accuracy) was >0.99 for remeasured versus original serum iohexol concentrations in all 3 cohorts, and Passing-Bablok regression did not find differences between measurements, except for a slope of 1.025 (95% CI, 1.006-1.046) for the log-transformed AGES-Kidney measurements. The multiple-sample iohexol clearance measurements in AGES-Kidney and BIS were compared with single-sample GFRs derived from the same iohexol measurements. Mean bias for multiple-sample relative to single-sample GFRs in AGES-Kidney and BIS were −0.25 and −0.15 mL/min, and 99% and 97% of absolute differences were within 10% of the multiple-sample result, ... Article in Journal/Newspaper North Norway University of Tromsø: Munin Open Research Archive Norway American Journal of Kidney Diseases 76 1 54 62
institution Open Polar
collection University of Tromsø: Munin Open Research Archive
op_collection_id ftunivtroemsoe
language English
description Rationale & Objective: Glomerular filtration rate (GFR) estimation based on creatinine or cystatin C level is currently the standard method for assessing GFR in epidemiologic research and clinical trials despite several important and well-known limitations. Plasma iohexol clearance has been proposed as an inexpensive method for measuring GFR that could replace estimated GFR in many research projects. However, lack of standardization for iohexol assays and the use of different protocols such as single- and multiplesample methods could potentially hamper comparisons across studies. We compared iohexol assays and GFR measurement protocols in 3 population-based European cohorts. Study Design: Cross-sectional investigation. Setting & Participants: Participants in the Age, Gene/Environment Susceptibility-Kidney Study (AGES-Kidney; n = 805), the Berlin Initiative Study (BIS, n = 570), and the Renal Iohexol Clearance Survey Follow-up Study (RENIS-FU; n = 1,324). Tests Compared: High-performance liquid chromatography analyses of iohexol. Plasma iohexol clearance calculated using single- versus multiple-sample protocols. Outcomes: Measures of agreement between methods. Results: Frozen samples from the 3 studies were obtained and iohexol concentrations were remeasured in the laboratory at the University Hospital of North Norway. Lin’s concordance correlation coefficient ρ was >0.96 and Cb (accuracy) was >0.99 for remeasured versus original serum iohexol concentrations in all 3 cohorts, and Passing-Bablok regression did not find differences between measurements, except for a slope of 1.025 (95% CI, 1.006-1.046) for the log-transformed AGES-Kidney measurements. The multiple-sample iohexol clearance measurements in AGES-Kidney and BIS were compared with single-sample GFRs derived from the same iohexol measurements. Mean bias for multiple-sample relative to single-sample GFRs in AGES-Kidney and BIS were −0.25 and −0.15 mL/min, and 99% and 97% of absolute differences were within 10% of the multiple-sample result, ...
format Article in Journal/Newspaper
author Eriksen, Bjørn Odvar
Schaeffner, Elke
Melsom, Toralf
Ebert, Natalie
van der Giet, Markus
Gudnason, Vilmundur
Indridasson, Olafur S.
Karger, Amy B.
Levey, Andrew S.
Schuchardt, Mirjam
Sørensen, Liv Karin
Pálsson, Runólfur
spellingShingle Eriksen, Bjørn Odvar
Schaeffner, Elke
Melsom, Toralf
Ebert, Natalie
van der Giet, Markus
Gudnason, Vilmundur
Indridasson, Olafur S.
Karger, Amy B.
Levey, Andrew S.
Schuchardt, Mirjam
Sørensen, Liv Karin
Pálsson, Runólfur
Comparability of plasma iohexol clearance across population-based cohorts
author_facet Eriksen, Bjørn Odvar
Schaeffner, Elke
Melsom, Toralf
Ebert, Natalie
van der Giet, Markus
Gudnason, Vilmundur
Indridasson, Olafur S.
Karger, Amy B.
Levey, Andrew S.
Schuchardt, Mirjam
Sørensen, Liv Karin
Pálsson, Runólfur
author_sort Eriksen, Bjørn Odvar
title Comparability of plasma iohexol clearance across population-based cohorts
title_short Comparability of plasma iohexol clearance across population-based cohorts
title_full Comparability of plasma iohexol clearance across population-based cohorts
title_fullStr Comparability of plasma iohexol clearance across population-based cohorts
title_full_unstemmed Comparability of plasma iohexol clearance across population-based cohorts
title_sort comparability of plasma iohexol clearance across population-based cohorts
publisher Elsevier
publishDate 2019
url https://hdl.handle.net/10037/26856
https://doi.org/10.1053/j.ajkd.2019.10.008
geographic Norway
geographic_facet Norway
genre North Norway
genre_facet North Norway
op_relation American Journal of Kidney Diseases
Eriksen BO, Schaeffner E, Melsom T, Ebert N, van der Giet M, Gudnason V, Indridasson, Karger, Levey AS, Schuchardt, Sørensen LK, Pálsson R. Comparability of plasma iohexol clearance across population-based cohorts. American Journal of Kidney Diseases. 2019, 76(1):54-62.
FRIDAID 1779098
doi:10.1053/j.ajkd.2019.10.008
0272-6386
1523-6838
https://hdl.handle.net/10037/26856
op_rights openAccess
Copyright 2019 The Author(s)
op_doi https://doi.org/10.1053/j.ajkd.2019.10.008
container_title American Journal of Kidney Diseases
container_volume 76
container_issue 1
container_start_page 54
op_container_end_page 62
_version_ 1766140155018608640